C115H115N21O19S10 — CID 158432213
N-[2-(dimethylamino)ethyl]-N-ethyl-2-(3-methylsulfonylanilino)thieno[2,3-h]quinazoline-8-carboxamide;(4-hydroxypiperidin-1-yl)-[2-(3-methylsulfonylanilino)thieno[2,3-h]quinazolin-8-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[2-(3-methylsulfonylanilino)thieno[2,3-h]quinazolin-8-yl]methanone;[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]-[2-(3-methylsulfonylanilino)thieno[2,3-h]quinazolin-8-yl]methanone;N-[(2S)-1-methoxypropan-2-yl]-2-(3-methylsulfonylanilino)thieno[2,3-h]quinazoline-8-carboxamide (PubChem CID 158432213) has the molecular formula C115H115N21O19S10 and a molecular weight of 2415.98 g/mol. Its IUPAC name is N-[2-(dimethylamino)ethyl]-N-ethyl-2-(3-methylsulfonylanilino)thieno[2,3-h]quinazoline-8-carboxamide;(4-hydroxypiperidin-1-yl)-[2-(3-methylsulfonylanilino)thieno[2,3-h]quinazolin-8-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[2-(3-methylsulfonylanilino)thieno[2,3-h]quinazolin-8-yl]methanone;[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]-[2-(3-methylsulfonylanilino)thieno[2,3-h]quinazolin-8-yl]methanone;N-[(2S)-1-methoxypropan-2-yl]-2-(3-methylsulfonylanilino)thieno[2,3-h]quinazoline-8-carboxamide.
| Compound Name | N-[2-(dimethylamino)ethyl]-N-ethyl-2-(3-methylsulfonylanilino)thieno[2,3-h]quinazoline-8-carboxamide;(4-hydroxypiperidin-1-yl)-[2-(3-methylsulfonylanilino)thieno[2,3-h]quinazolin-8-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[2-(3-methylsulfonylanilino)thieno[2,3-h]quinazolin-8-yl]methanone;[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]-[2-(3-methylsulfonylanilino)thieno[2,3-h]quinazolin-8-yl]methanone;N-[(2S)-1-methoxypropan-2-yl]-2-(3-methylsulfonylanilino)thieno[2,3-h]quinazoline-8-carboxamide |
|---|---|
| PubChem CID | 158432213 |
| Molecular Formula | C115H115N21O19S10 |
| Molecular Weight | 2415.98 g/mol |
| Exact Mass | 2413.59 |
| IUPAC Name | N-[2-(dimethylamino)ethyl]-N-ethyl-2-(3-methylsulfonylanilino)thieno[2,3-h]quinazoline-8-carboxamide;(4-hydroxypiperidin-1-yl)-[2-(3-methylsulfonylanilino)thieno[2,3-h]quinazolin-8-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[2-(3-methylsulfonylanilino)thieno[2,3-h]quinazolin-8-yl]methanone;[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]-[2-(3-methylsulfonylanilino)thieno[2,3-h]quinazolin-8-yl]methanone;N-[(2S)-1-methoxypropan-2-yl]-2-(3-methylsulfonylanilino)thieno[2,3-h]quinazoline-8-carboxamide |
| SMILES | CCN(CCN(C)C)C(=O)c1cc2c(ccc3cnc(Nc4cccc(S(C)(=O)=O)c4)nc32)s1.COC[C@H](C)NC(=O)c1cc2c(ccc3cnc(Nc4cccc(S(C)(=O)=O)c4)nc32)s1.COC[C@H]1CCCN1C(=O)c1cc2c(ccc3cnc(Nc4cccc(S(C)(=O)=O)c4)nc32)s1.CS(=O)(=O)c1cccc(Nc2ncc3ccc4sc(C(=O)N5CCC(O)C5)cc4c3n2)c1.CS(=O)(=O)c1cccc(Nc2ncc3ccc4sc(C(=O)N5CCC(O)CC5)cc4c3n2)c1 |
| InChI | InChI=1S/C24H27N5O3S2.C24H24N4O4S2.C23H22N4O4S2.C22H20N4O4S2.C22H22N4O4S2/c1-5-29(12-11-28(2)3)23(30)21-14-19-20(33-21)10-9-16-15-25-24(27-22(16)19)26-17-7-6-8-18(13-17)34(4,31)32;1-32-14-17-6-4-10-28(17)23(29)21-12-19-20(33-21)9-8-15-13-25-24(27-22(15)19)26-16-5-3-7-18(11-16)34(2,30)31;1-33(30,31)17-4-2-3-15(11-17)25-23-24-13-14-5-6-19-18(21(14)26-23)12-20(32-19)22(29)27-9-7-16(28)8-10-27;1-32(29,30)16-4-2-3-14(9-16)24-22-23-11-13-5-6-18-17(20(13)25-22)10-19(31-18)21(28)26-8-7-15(27)12-26;1-13(12-30-2)24-21(27)19-10-17-18(31-19)8-7-14-11-23-22(26-20(14)17)25-15-5-4-6-16(9-15)32(3,28)29/h6-10,13-15H,5,11-12H2,1-4H3,(H,25,26,27);3,5,7-9,11-13,17H,4,6,10,14H2,1-2H3,(H,25,26,27);2-6,11-13,16,28H,7-10H2,1H3,(H,24,25,26);2-6,9-11,15,27H,7-8,12H2,1H3,(H,23,24,25);4-11,13H,12H2,1-3H3,(H,24,27)(H,23,25,26)/t;17-;;;13-/m.1..0/s1 |
| InChIKey | HBUGLBZVKOOSOI-RTILXNMHSA-N |
| XLogP | 18.80 |
| TPSA | 532.25 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 40 |
| Rotatable Bonds | 29 |
| Heavy Atoms | 165 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2415.98 |
| LogP ≤ 5 | 18.80 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 40 |